USD 1.06 billion
Report ID: SQMIG35D2102 | Region: Global | Published Date: October, 2023 | Pages: 157 | Tables: 122 | Figures: 77
Middle East and Africa Stem Cell Market size was valued at USD 1.06 billion in 2021 and is poised to grow from USD 1.35 billion in 2022 to USD 4.50 billion by 2030, growing at a CAGR of 16.20% during the forecast period (2023-2030).
The Middle East and Africa region has witnessed significant advancements in the field of stem cell therapy, which has opened new avenues for treating various diseases and conditions. Extensive stem cell research is being conducted in the Middle East and Africa, focusing on understanding the potential of stem cells in treating a wide range of medical conditions. Researchers are exploring innovative approaches to harness the therapeutic potential of stem cells, such as stem cell injection techniques. Stem cell treatment has shown promising results in various areas, including regenerative medicine and tissue engineering. For instance, stem cell therapy for knees aims to repair damaged knee tissues and alleviate pain associated with conditions like osteoarthritis. The development of advanced stem cell technologies has played a crucial role in the progress of stem cell therapy in the region. These technologies enable the isolation, expansion, and manipulation of stem cells for therapeutic purposes, leading to improved treatment outcomes. The Middle East and Africa stem cell market is witnessing steady growth due to the increasing adoption of stem cell therapy for various medical conditions. The market offers a wide range of stem cell-based treatments, including those targeting neurodegenerative disorders, cardiovascular diseases, and orthopedic conditions.
Global Market Size
USD 1.06 billion
Autologous Stem Cell Therapy
Autologous Stem Cell Therapy
To get more reports on the above market click here to Buy The Report
The Middle East and Africa Stem Cell Market is segmented by Type, product, application, end-user and region. Based on type, the market can be segmented into allogenic stem cell therapy, and autologous stem cell therapy. Based on product, the market is segmented into bone marrow derived mesenchymal stem cells, placental or umbilical stem cells, adipose tissue derived mesenchymal stem cells, and others. Based on application, the Middle East and Africa stem cell therapy market is segmented into musculoskeletal disorders, wounds and injuries, acute graft-versus-host disease (AGVHD), surgeries, gastrointestinal diseases, cardiovascular diseases, and others. Based on end user, the Middle East and Africa stem cell therapy market is segmented into hospitals and surgical centers, therapeutic companies, services companies, and others. Based on region, the market is segmented into Israel, Turkey, South Africa, Saudi Arabia, and Rest of Middle East & Africa.
Middle East and Africa Stem Cell Market Analysis by Type
By Type, the market can be segmented into allogenic stem cell therapy, and autologous stem cell therapy. Autologous stem cell therapy holds the dominant position in the Middle East and Africa stem cell therapy market. This segment's dominance can be attributed to several factors. Autologous stem cell therapy involves the use of a patient's own stem cells, which are collected, processed, and re-infused back into the patient's body for therapeutic purposes. This approach offers several advantages, including a reduced risk of immune rejection and graft-versus-host disease, as the patient's own cells are used. Autologous stem cell therapy also eliminates the need for immunosuppressive drugs, making it a safer option for patients. Additionally, the availability and accessibility of patients' own stem cells are relatively higher compared to obtaining cells from other sources.
The fastest growing segment in the Middle East and Africa stem cell therapy market is allogenic stem cell therapy. Allogenic stem cell therapy involves using stem cells derived from a donor, either from a related or unrelated individual. This approach offers certain advantages, such as a readily available source of stem cells and the potential for treating a broader range of patients who may not have suitable autologous cells. Allogenic stem cell therapy also allows for the creation of standardized and off-the-shelf products, which can be more convenient and cost-effective. The growing advancements in immunosuppression techniques, ensuring a lower risk of graft rejection or adverse immune reactions, have further fueled the growth of allogenic stem cell therapy.
Middle East and Africa Stem Cell Market Analysis by Application
By application, the market can be segmented into bone marrow derived mesenchymal stem cells, placental or umbilical stem cell, adipose tissue derived mesenchymal stem cells, and others. Bone marrow derived mesenchymal stem cells have established themselves as the dominant segment in the Middle East and Africa stem cell therapy market. This dominance can be attributed to several factors. Firstly, bone marrow-derived mesenchymal stem cells have been extensively researched and studied, making them a well-understood and validated treatment option. The clinical efficacy and safety profile of these cells have been demonstrated in various therapeutic applications, including regenerative medicine and immunotherapy. Furthermore, bone marrow derived mesenchymal stem cells offer advantages such as easy accessibility, abundance, and multi-lineage differentiation potential, which contribute to their widespread use in clinical practice.
The fastest growing segment in the Middle East and Africa stem cell therapy market is placental or umbilical stem cells. Placental or umbilical stem cells possess unique characteristics that make them attractive for therapeutic applications. These cells are derived from the umbilical cord or placenta, which are typically discarded after childbirth, making their collection non-invasive and ethical. Placental or umbilical stem cells are a rich source of hematopoietic and mesenchymal stem cells, with high proliferative capacity and low immunogenicity. These cells also have a lower risk of transmitting infections compared to other sources.
To get detailed analysis on other segments, Request For Sample Report
The United Arab Emirates has emerged as a major hub for medical tourism and advanced healthcare infrastructure. The country has made substantial investments in stem cell research and therapy, attracting patients from around the world seeking innovative treatments. The UAE boasts state-of-the-art stem cell facilities and clinics that offer a wide range of stem cell therapies, including treatments for orthopedic conditions, neurodegenerative disorders, and cardiovascular diseases. The country's favorable regulatory environment and collaborations with leading international research institutions have further boosted its dominance in the stem cells market.
On the other hand, South Africa is experiencing rapid growth in the stem cells market. The country has a well-developed healthcare system and a growing focus on regenerative medicine. South Africa has been actively involved in stem cell research, exploring its potential in treating various diseases, including HIV/AIDS, diabetes, and spinal cord injuries. The government's support for stem cell research and the presence of renowned stem cell research centers and universities have contributed to South Africa's emergence as a key player in the field.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Middle East and Africa Stem Cell Market Drivers
Increasing prevalence of chronic diseases and age-related conditions
Middle East and Africa Stem Cell Market Restraints
Lack of standardized regulations and guidelines for stem cell therapy
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Middle East and Africa Stem cell market is characterized by a diverse range of companies and research institutions. Several local and international players are actively engaged in stem cell research, therapy, and technology development. These participants vary in terms of their areas of focus, expertise, and market presence. The market is witnessing collaborations and partnerships between research institutions, healthcare providers, and pharmaceutical companies to drive innovation and accelerate the development of stem cell-based treatments. Additionally, academic institutions and government organizations play a significant role in funding and supporting stem cell research initiatives. The competitive landscape is dynamic, with a focus on advancing stem cell technologies and expanding the therapeutic applications of stem cells in the region.
Middle East and Africa Stem Cell Market Top Player’s Company Profiles
Middle East and Africa Stem Cell Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Middle East and Africa stem cells market analysis, the market holds significant potential for future growth and advancements in the field of regenerative medicine. Stem cell therapies offer promising solutions for a wide range of diseases and conditions, driving the market expansion. The growing prevalence of chronic diseases and age-related conditions serves as the most driving factor for the market's growth, creating a strong demand for effective and innovative treatments. In terms of segments, the largest segment lies in the application of stem cell therapies for orthopedic conditions, while the fastest-growing segment is anticipated to be in neurodegenerative disorders. The United Arab Emirates emerges as the dominating country in the region, benefiting from advanced healthcare infrastructure and favorable regulatory environments. As research and technological advancements continue, the Middle East and Africa stem cells market is poised for significant growth and transformation in the coming years.
|Market size value in 2021||USD 1.06 billion|
|Market size value in 2030||USD 1.35 billion|
|Forecast Unit (Value)||USD Billion|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Middle East and Africa Stem Cell Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Middle East and Africa Stem Cell Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Middle East and Africa Stem Cell Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Middle East and Africa Stem Cell Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.